Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.
McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–28.
Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–5.
Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989;9:691–6.
Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–34.
Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol. 2004;15:1197–207.
Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischaemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–71.
Schanzer A, Goodney PP, YouFu L, et al. Validation of the PIII CLI Risk Score for the prediction of amputation-free survival in patients undergoing surgical bypass for critical limb ischaemia. J Vasc Surg. 2009;50:769–75.
Rose SC. Noninvasive vascular laboratory for evaluation of peripheral arterial occlusive disease. Part II. Clinical applications: chronic atherosclerotic, lower extremity ischaemia. J Vasc Interv Radiol. 2000;11:1257–75.
Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg. 1997;25:365–79.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA. Fowkes FGR on behalf of the TASC II working group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S54–7.
Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. Br J Surg. 2005;92:565–9.
Kim YW, Lee JH, Kim HG, Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg. 2005;30:376–80.
AbuRahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg. 2001;33:S93–9.
Ricco JB, Probst H. French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008;47:45–53.
Porter JM, Eidemiller LR, Dotter CT, Rosch J, Vetto RM. Combined arterial dilatation and femorofemoral bypass for limb salvage. Surg Gynecol Obstet. 1973;137:409–12.
Walker PJ, Harris JP, May J. Combined percutaneous transluminal angioplasty and extra-anatomic bypass for symptomatic unilateral iliac occlusion with contralateral iliac artery stenosis. Ann Vasc Surg. 1991;5:209–17.
Shah RM, Peer RM, Upson JF, Ricotta JJ. Donor iliac angioplasty and crossover femorofemoral bypass. Am J Surg. 1992;164:295–8.
Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass. Analysis of 70 consecutive cases with long-term follow-up. J Vasc Surg. 1996;24:363–70.
Schneider JR, Besso SR, Walsh DB, Zwolack RM, Cronenwett JL. Femorofemoral versus aortofemoral bypass. Outcome and hemodynamic results. J Vasc Surg. 1994;19:43–57.
Criado E, Burnham SJ, Tinsley EA, Johnson G, Keagy BA. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome. J Vasc Surg. 1993;18:495–505.
Brewster DC, Cambria RF, Darling RC, et al. Long-term results of combined iliac balloon angioplasty and distal surgical revascularization. Ann Surg. 1989;210:324–31.
Cynamon J, Marin ML, Veith FJ, et al. Stent-graft repair of aortoiliac occlusive disease coexisting with common femoral artery disease. J Vasc Interv Radiol. 1997;8:19–26.
Heart Protection Study Collaborative Group. Randomised trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20, 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ricco, JB., Page, O. (2018). Lower Limb Claudication Due to Bilateral Iliac Artery Occlusive Disease: The Case for Iliac Stenting and Femorofemoral Crossover Bypass. In: Geroulakos, G., Sumpio, B. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-65936-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-65936-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65935-0
Online ISBN: 978-3-319-65936-7
eBook Packages: MedicineMedicine (R0)